Barbara Alicja Jereczek‐Fossa
A5054413808- Advanced Radiotherapy Techniques
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Head and Neck Cancer Studies
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Medical Imaging Techniques and Applications
- Radiation Therapy and Dosimetry
- Advances in Oncology and Radiotherapy
- Bladder and Urothelial Cancer Treatments
- Cancer Diagnosis and Treatment
- MRI in cancer diagnosis
- Management of metastatic bone disease
- Lung Cancer Research Studies
- Radiation Dose and Imaging
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Breast Lesions and Carcinomas
- Radiopharmaceutical Chemistry and Applications
- Endometrial and Cervical Cancer Treatments
- Effects of Radiation Exposure
- COVID-19 and healthcare impacts
- Advanced X-ray and CT Imaging
- Oral health in cancer treatment
European Institute of Oncology
2016-2025
University of Milan
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2018-2024
Ripamonti
2015-2024
European Society for Therapeutic Radiology and Oncology
2022-2023
Medical University of Vienna
2022
University of Port Harcourt Teaching Hospital
2022
Marqués de Valdecilla University Hospital
2022
Royal Marsden NHS Foundation Trust
2022
Instituto de Investigación Marqués de Valdecilla
2022
Innovations in imaging and molecular characterisation the evolution of new therapies have improved outcomes advanced prostate cancer. Nonetheless, we continue to lack high-level evidence on a variety clinical topics that greatly impact daily practice. To supplement evidence-based guidelines, 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) surveyed experts about key dilemmas management.To present consensus voting results for select questions from APCCC 2022.Before conference,...
Abstract Background Recent studies have reported improvement of outcomes (progression-free survival, overall and prolongation androgen deprivation treatment-free survival) with stereotactic body radiotherapy (SBRT) in non-small cell lung cancer prostate cancer. The aim this retrospective, multicenter study (MITO RT-01) was to define activity safety SBRT a very large, real-world data set patients metastatic, persistent, recurrent ovarian (MPR-OC). Materials Methods endpoints the were rate...
Background and purposeOligometastatic prostate cancer is a new emerging treatment field with only few prospective randomized studies published so far. Despite the lack of strong level I evidence, metastasis-directed therapies (MDT) are widely used in clinical practice, mainly based on retrospective small phase 2 large difference across centers. Pending results ongoing trials, there clear need for more consistent indications radiotherapy practices.Material methodsA European Society...
Innovations have improved outcomes in advanced prostate cancer (PC). Nonetheless, we continue to lack high-level evidence on a variety of topics that greatly impact daily practice. The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) surveyed experts key questions clinical management order supplement evidence-based guidelines. Here present voting results for from APCCC 2024.